Company overview
Twist Bioscience provides synthetic DNA products including genes, oligo pools, NGS tools, and antibody libraries for pharmaceutical R&D and drug discovery. Their proprietary silicon-based platform enables high-throughput, cost-effective DNA synthesis up to 5kb genes with rapid turnaround. They support pre-clinical studies with research-grade plasmid preps and biopharma solutions for antibody optimization.
Twist Bioscience is listed in the NovaPharmaNews Supplier Hub as a Life Science Reagents partner serving United States & Americas. Core focus areas include dna synthesis, synthetic genes, ngs tools, antibody libraries, biopharma solutions.
Industry categories: Life Science Reagents. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://www.twistbioscience.com
- Categories
- Life Science Reagents
- Markets served
- United States & Americas
- Keywords
- dna synthesis, synthetic genes, ngs tools, antibody libraries, biopharma solutions
Products & technologies
Therapeutic areas
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What DNA synthesis capabilities does Twist Bioscience offer for pharma R&D?
- Twist offers synthetic genes up to 5kb, oligo pools, NGS preparation tools, antibody libraries, and plasmid DNA preps using a proprietary silicon chip platform for high-throughput production.
- What is the turnaround time and pricing for Twist's synthetic genes?
- Genes up to 5kb are offered at $0.15 per base pair with 15-25 day turnaround, supported by an API for streamlined ordering and pathway design.
- How does Twist support drug discovery and biopharma applications?
- Twist Biopharma Solutions provide antibody libraries and optimization tools built from synthetic DNA on silicon chips, enabling rapid high-quality DNA delivery for projects.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
